Workplace Carcinogen Risk Assessment Ireland

An Irish workplace carcinogen risk assessment should identify the hazardous agent or process, describe exactly how exposure can occur, show who may be exposed and for how long, and record why each prevention or control measure is suitable. It should cover purchased products and substances generated by the work itself—not just copy information from a safety data sheet.

The short answer

Assess each activity before the work starts. Check labels, safety data sheets and Schedule 4 of the HSA's 2026 Code of Practice; consider inhalation, skin contact and other exposure routes; eliminate or substitute where possible; and record the engineering, work-practice and residual controls needed. Give every improvement an owner and due date, consult the people doing the work, and review the assessment when the work changes and at least annually.

Which substances and processes are in scope?

In Ireland, the Safety, Health and Welfare at Work (Carcinogens, Mutagens and Reprotoxic Substances) Regulations 2024, as amended in 2026, apply alongside the Chemical Agents Regulations. The HSA says the carcinogens regulations cover Category 1A and 1B carcinogens, mutagens and reprotoxic substances, together with carcinogenic and mutagenic substances, mixtures and processes listed in Schedule 4 of the current Code of Practice.

For a supplied substance or mixture, check the label and safety data sheet. HSA guidance highlights these hazard statements:

H350: may cause cancer.
H350i: may cause cancer by inhalation.
H340: may cause genetic defects.
H360: may damage fertility or the unborn child.

Do not stop at the chemical store. The HSA tells employers to include agents generated by work activities or waste, such as fumes, dusts and residues, and to check Schedule 4. Hazardous medicinal products may also fall within scope. A product-level inventory is useful evidence, but the assessment has to follow the activity: how the agent is stored, moved, used, generated and disposed of.

Important distinction

A UK COSHH assessment does not meet Irish legal requirements. The HSA states that COSHH is UK legislation and that a generic chemical assessment is unlikely to meet the requirements of Irish chemical-agent law.

What should the assessment record?

A practical assessment should be detailed enough for a supervisor to understand the risk and verify the controls at the point of work. Record at least the following:

Activity and location: the task, process, equipment and site or work area being assessed.
Agent or process: the product name, hazardous component, classification, relevant safety data sheet and any Schedule 4 process or release.
How exposure happens: whether the agent is poured, sprayed, heated, cut, sanded, generated as dust or fume, or released during cleaning, maintenance or waste handling.
Exposure route and pattern: inhalation, skin or eye contact, ingestion or other route; the quantity used or generated; frequency; duration; and whether several agents are present together.
People affected: operators, cleaners, maintenance staff, contractors, nearby workers, visitors and any vulnerable groups.
Existing evidence: exposure measurements, inspection findings, ventilation checks, health information and previous incidents or complaints where relevant.
Prevention decision: whether elimination or substitution is possible and, if it is not selected, the technical and operational basis for that decision.
Controls and verification: containment or extraction, safe work methods, hygiene and storage arrangements, restricted access, training, PPE or RPE, and how each control will be checked and maintained.
Emergency arrangements: the response to a spill, accidental release, control failure or other foreseeable event.
Actions: the improvement required, responsible person, target date, status and evidence of close-out.

The assessment should link to current supporting documents rather than reproduce them inaccurately. A safety data sheet describes a product's hazards and handling advice; it does not describe the exposure created by your particular task, site, people or controls.

How should controls be selected?

The control decision must follow the hierarchy. The HSA's chemical risk-assessment guidance says to consider eliminating the hazard by changing the process or removing the hazardous chemical first. If elimination is not possible, consider a non-hazardous or less hazardous substitute. Only then should the assessment move through additional measures to remove or reduce exposure.

Eliminate: remove the agent or redesign the task so the exposure is not created.
Substitute: use a safer substance, formulation or physical form where technically possible.
Engineer out exposure: use isolation, containment, local exhaust ventilation or on-tool extraction suited to the process.
Improve the method: reduce the quantity, frequency, duration and number of people exposed; control access; and define cleaning, storage and disposal arrangements.
Inform and train: explain the health risk, correct work method, signs of control failure and required emergency response.
Protect residual risk: specify suitable PPE or RPE only after the preceding measures. Record the exact type and the arrangements for fitting, use, maintenance and replacement.

Do not write “wear a mask” as the main control for an airborne carcinogen. A useful entry identifies the source control, states how its performance will be checked and makes clear what the worker should do if the control is unavailable or fails.

What does a useful assessment look like?

Consider a maintenance task that creates hazardous dust. A weak record says “dust—wear PPE.” A useful record separates the decisions:

The task, material and dust-generating step are identified.
The assessor checks classification information and whether the substance, process or release appears in Schedule 4.
Normal work, set-up, cleaning, filter changes, breakdowns and waste disposal are considered.
Operators, maintenance staff, cleaners and people working nearby are included.
A lower-exposure method is considered before extraction and RPE are selected.
Extraction performance, pre-use checks and planned maintenance have named owners and frequencies.
Access and housekeeping controls prevent dust spreading to adjacent areas.
Residual RPE is specified, fit requirements are addressed and workers know what to do if extraction fails.
Any monitoring or health-surveillance decision is made with competent occupational hygiene or health advice where necessary.

The final risk rating matters less than the quality of the evidence and actions behind it. A colourful matrix cannot compensate for a missing exposure pathway or an unverified control.

How should multi-site operators manage it?

Central teams can standardise the hazard information and minimum control standard, but every site still needs to confirm the actual activity and exposure. The same product can create different risks when one site brushes it on, another sprays it, and a third only stores unopened containers.

For distributed operations, use a two-layer record:

Central standard: approved substances and processes, current safety data sheets, prohibited substitutions, minimum engineering controls, required competence and escalation rules.
Site assessment: local quantity and frequency, equipment and extraction, room layout, people affected, inspection evidence, actions and sign-off.

Trend the actions as well as completed assessments. Repeated overdue extraction checks, missing safety data sheets or unapproved product changes are management signals even when each site has an assessment on file.

Keep actions visible across sites

Fit2Trade Ensure supports structured safety workflows, risks, incidents and corrective actions with visibility across locations. Use it to keep ownership, due dates and close-out evidence connected to the work being managed.

Explore Fit2Trade Ensure

When should it be reviewed?

The HSA advises reviewing chemical risk assessments at least once a year and updating them when necessary. Do not wait for the annual date when circumstances change. Review before introducing a new activity and when there is a new substance, formulation, supplier, process, machine, extraction system, work pattern or group of exposed people. Also review after a spill, control failure, exposure result, health concern, incident or other evidence that the existing assessment may no longer be adequate.

For a new activity involving hazardous chemical agents, the HSA states that work must not begin until the risk has been assessed and the identified preventive measures have been implemented.

The HSA's 28 October 2026 conference on respirable carcinogens is a current reminder of the scale of occupational disease: the Authority cited an estimate of approximately 400 deaths each year in Ireland from exposure to carcinogens at work. The conference did not create a new legal duty. The relevant duties already arise under Irish workplace safety and chemical legislation, supported by the 2026 Code of Practice, which has been effective since 9 April 2026.

Primary sources

This article is general information for Irish employers and safety practitioners. It does not replace a competent assessment of the substances, processes and exposure conditions in a particular workplace.

What Should an Irish Workplace Carcinogen Risk Assessment Cover?